NCT01408732 Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia Status COMPLETED Phase PHASE1/PHASE2
NCT01408030 North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Status COMPLETED Phase PHASE2
NCT01314274 Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Status COMPLETED Phase PHASE2
NCT00863356 Trial of a Novel Chitosan Hemostatic Sealant in the Management of Complicated Epistaxis Status COMPLETED Phase NA
NCT00814333 Trial Comparing Outcomes With Merocel Packing or Thrombin-JMI for Anterior Epistaxis Status TERMINATED Phase NA
NCT00390663 A Prospective Randomised Controlled Trial of Management of Recurrent Nosebleeds in Children Status UNKNOWN Phase PHASE4